Botanical Solution Inc., a Delaware Corporation, has a proprietary platform for sustainable and improved production of consistent, high quality Advanced Botanical Materials (ABM). ABM-01 is the first ABM produced by the company, based on a plant called Quillaja saponaria. ABM-01 is the active ingredient used in two gold standard products, BSI's biopesticide Quillibrium and the vaccine adjuvant QS-21, used in a Shingles blockbuster vaccine, a recently launched RSV vaccine and a Malaria vaccine.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/23/23 | $7,000,000 |
Otter Capital | undisclosed | |
| 08/20/24 | $7,600,000 | Series A |
